The medical cannabis industry has become more globalised than ever, and this trend shows no indication of slowing down. Medical cannabis markets such as Australia and Germany have matured and increasingly rely upon imports to supply their domestic programmes, while countries like Canada, Colombia and Portugal have grown their exports substantially in the last few years and established themselves as export markets.
The regulation of medical cannabis trade, however, remains complex with little harmonisation.
This report examines the regulatory requirements for importing and exporting medical cannabis in the most active trade markets in the world. The most active markets examined in this report were determined based on data published by the International Narcotics Control Board (INCB), data published by national authorities and developments tracked by CannIntelligence.